Skip to content

Study on Effectiveness Verification of Specific Health Guidance Utilizing Information and Communications Technology (ICT)

Study on Effectiveness Verification of Specific Health Guidance Utilizing Information and Communications Technology (ICT)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1090220315
Enrollment
200
Registered
2017-11-16
Start date
2017-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lifestyle-related diseases

Interventions

Intervention type:BEHAVIOUR Name of intervention:Lifestyle improvement by health guidance utilizing information technology(IT) Dose form / Japanese Medical Device Nomenclature:NOT APPLICABLE Route of

Sponsors

Yumi Matsushita
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Those who satisfy all of the following conditions: 1. Person who has received the specific health check-up and been assigned to the active support group 2. Age: Males and females between 40 and 64 years old 3. Person who has smartphone 4. Person who satisfies the following essential item (1) as well as two or more of other items from (2) to (5): (1) Male: Waist circumference 85cm or more; Female: waist circumference 90cm or more (2) TG 150 mg/dl or more (3) HDL cholesterol less than 40 mg/dl (4) SBP 130 mmHg or more, and/or DBP 85 mmHg or more (5) FPG 110 mg/dl or more 5. Person taking no drugs related to weight loss and metabolic syndrome (except for vitamin supplements)

Exclusion criteria

Exclusion criteria: 1. Person who has a history of cerebral cardiovascular disease 2. Person with lung disease 3. Person who cannot expect to continue the participation for 6 months (for example, scheduled moving within 6 months etc.) 4. Person judged by doctors that participation is not appropriate 5. Person who is pregnant 6. Person taking drugs related to weight loss or metabolic syndrome (diabetes, hypertension, hyperlipidemia) (except for vitamin supplements)

Design outcomes

Primary

MeasureTime frame
Variation in the body weight (kg) between the baseline and 3 months

Secondary

MeasureTime frame
Variations (continuous values) in the items described below during the study duration, between the baseline and 3 months, or onset (categorical value)

Countries

Japan

Contacts

Public ContactYumi Matsushita

National Center for Global Health and Medicine

ymatsushita@hosp.ncgm.go.jp+81-3-3202-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026